SimonManthaMDMPH

Blood Banking & Transfusion Medicine, Clotting Disorder

Associate Attending

Overview of Dr. Mantha

I am a clinical hematologist with special interests in cancer-associated disorders of hemostasis, genomics, big data and machine learning. My recent work includes an assessment of cancer-specific genetic alterations modulating the risk of thromboembolism, and application of this knowledge to predict clinical events using random survival forests. In the last year I have also developed CEDARS, a simple and efficient pipeline for electronic health record annotation.

Office
530 East 74th Street
New York, NY 10021
Book by Phone+1(719) 299-3610

Education & Training

Harvard UniversityMPH, Public Health, 2010
Yale-New Haven Medical CenterFellowship, Blood Banking/Transfusion Medicine, 2005 - 2006
New York Presbyterian Hospital (Cornell Campus)Fellowship, Hematology and Medical Oncology, 2002 - 2005
Laval UnivClass of 1999

Certifications & Licensure

FL State Medical License 2022 - Present
NJ State Medical License 2018 - 2025
NY State Medical License 2012 - 2025
CT State Medical License 2024 - 2024
MA State Medical License 2006 - 2012
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Pathology Blood Banking/Transfusion Medicine

Publications & Presentations

PubMed

1 citations
DNA liquid biopsy-based prediction of cancer-associated venous thromboembolism.
Justin Jee, A Rose Brannon, Rohan Singh, Andriy Derkach, Christopher Fong
Nature Medicine. 2024-09-01
338 citations
Cancer therapy shapes the fitness landscape of clonal hematopoiesis
Kelly L. Bolton, Ryan Ptashkin, Teng Gao, Lior Z. Braunstein, Sean M. Devlin
Nature Genetics. 2020-10-26
70 citations
Determinants of fatal bleeding during induction therapy for acute promyelocytic leukemia in the ATRA era
Simon Mantha, Debra A. Goldman, Sean M. Devlin, Ju Whei Lee, Diana Zannino
Blood. 2014-12-06

Abstracts/Posters

Extended Mutational Profiling By MSK-IMPACTTM Identifies Mutations Predicting Thromboembolic Risk in Patients with Solid Tumor MalignancyClinically Relevant Abstract
Simon Mantha, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Lectures

Hypofibrinogenemia and Disseminated Intravascular Coagulation Rarely Complicate Treatment-Naive Acute Lymphoblastic Leukemia
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Cancer-Associated Thrombosis: Anatomic Distribution of the Index Event Is Not a Reliable Predictor of Recurrence Risk
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018